Lianhua Respiratory Fusion Cell Virus/Adenovirus 2-in-1 Antigen Detection Reagent - Taiwan Registration c681b13ced05ff6e69bd3afb957d8ad8
Access comprehensive regulatory information for Lianhua Respiratory Fusion Cell Virus/Adenovirus 2-in-1 Antigen Detection Reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number c681b13ced05ff6e69bd3afb957d8ad8 and manufactured by FIRSTEP BIORESEARCH INC.. The authorized representative in Taiwan is FIRSTEP BIORESEARCH INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
It is limited to the first level of identification of "Respiratory Fusion Cell Virus Serum Reagent (C.3480)", "Adenovirus Serum Reagent (C.3020)", and "Microbial Sample Collection and Delivery Equipment (C.2900)" of the Classification and Grading Management Measures for Medical Devices.
C Immunology and microbiology
C.3480 ๅผๅธ้่ๅ็ดฐ่็ ๆฏ่กๆธ ่ฉฆๅ;; C.3020 ่ บ็ ๆฏ่กๆธ ่ฉฆๅ;; C.2900 ๅพฎ็็ฉๆจฃๆฌๆถ้ๅ่ผธ้ๅจๆ
QMS/QSD;; ๅ็ข
Dates and Status
Nov 01, 2024
Nov 01, 2029